Report on Lipid-Lowering Drugs Market
China's morbidity rate of hyperlipemia reaches above 7%, with 90 million patients, thus the lipid-lowering drugs market is a market of huge demand. This report analyzes the classification of hyperlipemia, drug market, and manufacturing enterprises, and mainly researches on the three types of lipid-lowering drugs (statin, nicotinic acid and its derivation, fibrate ) in current market.
1 INTRODUCTION OF HYPERLIPEMIA
1.1 Classification of hyperlipemia
1.2 Types of hypolipidemic drugs
2 MARKET ANALYSIS OF HYPOLIPIDEMIC DRUGS
2.1 Market share of hypolipidemic drugs
2.2 Market analysis of statin lipid lowering medicine
2.3 Market analysis of nicotinic acid and its derivative lipid lowering medicine
2.4 Market analysis fibrate lipid lowering medicine
3 MANUFACTURING ENTERPRISE OF LIPID-LOWERING DRUGS
1.1 Classification of hyperlipemia
1.2 Types of hypolipidemic drugs
2 MARKET ANALYSIS OF HYPOLIPIDEMIC DRUGS
2.1 Market share of hypolipidemic drugs
2.2 Market analysis of statin lipid lowering medicine
2.3 Market analysis of nicotinic acid and its derivative lipid lowering medicine
2.4 Market analysis fibrate lipid lowering medicine
3 MANUFACTURING ENTERPRISE OF LIPID-LOWERING DRUGS
